TY  - JOUR
AU  - Klepser, Donald G.
AU  - Klepser, Michael E.
AU  - Peters, Philip J.
AU  - Hoover, Karen W.
AU  - Weidle, Paul J.
PY  - 2022
TI  - Implementation and Evaluation of a Collaborative, Pharmacy-Based Hepatitis C and HIV Screening Program
T2  - Preventing Chronic Disease
JO  - Prev Chronic Dis
SP  - E83
VL  - 19
CY  - Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA.
N2  - INTRODUCTION  Pharmacy-based HIV and hepatitis C virus (HCV) screening services developed in conjunction with state and local health departments can improve public health through increased access to testing and a linkage-to-care strategy. The objective of this study was to evaluate the impact of implementing HIV and HCV screening in community pharmacies. METHODS  This prospective, multicenter implementation project was conducted from July 2015 through August 2018. Sixty-one pharmacies participated in 3 US regions. We assessed the effectiveness of point-of-care testing, counseling, and disease education for populations at increased risk for HIV and HCV infection through screening programs offered in community pharmacies. Pharmacy customers were offered screening with point-of-care HIV and/or HCV tests. Reactive test results were reported to state or local health departments for disease surveillance. RESULTS  A total of 1,164 patients were screened for HIV, HCV, or both at the 61 participating pharmacies; the average number of patients screened per pharmacy was 19. Pharmacists conducted 1,479 HIV or HCV tests among the 1,164 patients. Five of 612 (0.8%) HIV tests yielded a reactive result, and 181 of 867 (20.9%) of HCV tests yielded a reactive result. CONCLUSION  Patients at increased risk of HIV or HCV can benefit from screening for infection at community pharmacies. Ease of accessibility to testing coupled with a strategy for linkage to care designed for the local community can improve patient care and improve the course of treatment for HIV and HCV.
SN  - 1545-1151
UR  - https://doi.org/10.5888/pcd19.220129
DO  - 10.5888/pcd19.220129
ER  -